FA
FSA Advisors, Inc.
13F filer · CIK 0001905627Reported Aug 17, 2026
13F portfolio value$218MU.S. long equity reported on 13F
Positions98Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight13.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 17, 202698 positions | |||||
| $4.17M | 1.91% | Not reported | +364.8% | Q4 2023 | |
| $4.03M | 1.85% | 0.00% | +2.5% | Q4 2023 | |
| $3.57M | 1.64% | 0.00% | Not reported | Q4 2023 | |
| $3.34M | 1.53% | 0.00% | +3.9% | Q4 2023 | |
| OBONEZOne Bio, Corp. | $3.18M | 1.46% | Not reported | +128.5% | Q1 2025 |
| $2.95M | 1.35% | Not reported | +6.5% | Q3 2024 | |
| $2.39M | 1.09% | Not reported | Not reported | Q3 2024 | |
| $2.37M | 1.09% | Not reported | +2.8% | Q4 2023 | |
| $2.28M | 1.04% | 0.00% | +3.1% | Q3 2024 | |
| $2.04M | 0.94% | Not reported | -2.5% | Q4 2023 | |
| $1.89M | 0.87% | 0.01% | -0.5% | Q4 2023 | |
| $1.59M | 0.73% | 0.00% | +0.2% | Q4 2023 | |
| $1.53M | 0.70% | 0.00% | +7.4% | Q2 2025 | |
| $1.42M | 0.65% | 0.00% | +9.9% | Q1 2026 | |
| $1.39M | 0.64% | 0.00% | +6.6% | Q4 2023 | |
| $1.35M | 0.62% | 0.00% | +4.7% | Q4 2023 | |
| $1.33M | 0.61% | Not reported | -1.1% | Q4 2023 | |
| $1.29M | 0.59% | 0.00% | +14.9% | Q4 2024 | |
| $1.25M | 0.58% | 0.00% | New | Q2 2026 | |
| $1.16M | 0.53% | Not reported | -2.4% | Q2 2025 | |
| $1.1M | 0.50% | 0.00% | -0.8% | Q4 2023 | |
| $1.05M | 0.48% | 0.00% | -30.1% | Q1 2026 | |
| $1.05M | 0.48% | Not reported | +256.2% | Q1 2026 | |
| $1.04M | 0.48% | 0.00% | Not reported | Q4 2023 | |
| $921K | 0.42% | 0.00% | +4.9% | Q1 2024 | |
| $872K | 0.40% | 0.01% | -0.4% | Q2 2024 | |
| $851K | 0.39% | 0.00% | +31.7% | Q1 2025 | |
| $830K | 0.38% | 0.00% | -1.6% | Q4 2024 | |
| $771K | 0.35% | Not reported | +0.3% | Q3 2024 | |
| $725K | 0.33% | Not reported | New | Q2 2026 | |
| $709K | 0.33% | Not reported | +4.8% | Q2 2025 | |
| $685K | 0.31% | 0.00% | +0.2% | Q3 2025 | |
| $569K | 0.26% | 0.00% | +14.3% | Q4 2023 | |
| $560K | 0.26% | Not reported | -19.5% | Q4 2023 | |
| $511K | 0.23% | 0.00% | +32.5% | Q1 2026 | |
| $502K | 0.23% | 0.00% | +0.8% | Q1 2025 | |
| $501K | 0.23% | 0.00% | New | Q2 2026 | |
| $483K | 0.22% | 0.00% | +32.9% | Q1 2026 | |
| $480K | 0.22% | 0.00% | Not reported | Q4 2024 | |
| $465K | 0.21% | Not reported | +10.7% | Q4 2023 | |
| $452K | 0.21% | 0.00% | Not reported | Q4 2023 | |
| $447K | 0.20% | 0.06% | Not reported | Q4 2023 | |
| $440K | 0.20% | 0.00% | -0.7% | Q1 2025 | |
| $439K | 0.20% | 0.00% | New | Q2 2026 | |
| $437K | 0.20% | 0.00% | Not reported | Q4 2023 | |
| $426K | 0.20% | 0.00% | -5.1% | Q1 2024 | |
| $423K | 0.19% | 0.00% | -42.5% | Q3 2024 | |
| $422K | 0.19% | 0.00% | -0.6% | Q1 2026 | |
| $422K | 0.19% | 0.00% | +12.7% | Q4 2025 | |
| $421K | 0.19% | 0.00% | Not reported | Q1 2024 | |
| Q1 2026Reported May 6, 202665 positions | |||||
| $3.43M | 2.26% | 0.00% | -86.7% | Q4 2023 | |
| $2.82M | 1.86% | 0.00% | +550.0% | Q4 2023 | |
| $2.69M | 1.77% | Not reported | +10.7% | Q3 2024 | |
| $2.01M | 1.32% | Not reported | -77.1% | Q4 2023 | |
| $1.89M | 1.25% | Not reported | -0.8% | Q4 2023 | |
| $1.82M | 1.20% | 0.01% | +84.9% | Q4 2023 | |
| $1.65M | 1.09% | 0.00% | +6.1% | Q3 2024 | |
| OBONEZOne Bio, Corp. | $1.26M | 0.83% | Not reported | Not reported | Q1 2025 |
| $1.25M | 0.82% | Not reported | -0.3% | Q4 2023 | |
| $1.14M | 0.75% | Not reported | +20.1% | Q2 2025 | |
| $1.12M | 0.74% | 0.00% | Not reported | Q4 2023 | |
| $1.06M | 0.70% | 0.00% | +20.9% | Q2 2025 | |
| $1.05M | 0.69% | 0.00% | +271.8% | Q4 2023 | |
| $1.04M | 0.69% | 0.00% | -96.5% | Q4 2023 | |
| $991K | 0.65% | 0.00% | -93.1% | Q4 2024 | |
| $990K | 0.65% | 0.00% | -93.4% | Q4 2023 | |
| $811K | 0.53% | 0.00% | Not reported | Q4 2024 | |
| $804K | 0.53% | 0.01% | +7.9% | Q2 2024 | |
| $721K | 0.48% | 0.00% | -95.8% | Q1 2024 | |
| $703K | 0.46% | Not reported | Not reported | Q4 2023 | |
| $699K | 0.46% | Not reported | -98.1% | Q4 2023 | |
| $650K | 0.43% | 0.00% | -84.1% | Q4 2023 | |
| $559K | 0.37% | 0.00% | -78.7% | Q1 2025 | |
| $548K | 0.36% | 0.00% | Not reported | Q3 2025 | |
| $529K | 0.35% | 0.00% | New | Q1 2026 | |
| $500K | 0.33% | 0.00% | -57.2% | Q4 2023 | |
| $486K | 0.32% | 0.00% | -89.1% | Q3 2024 | |
| $473K | 0.31% | 0.00% | -1.7% | Q1 2025 | |
| $471K | 0.31% | 0.00% | Not reported | Q3 2025 | |
| $465K | 0.31% | 0.00% | -4.0% | Q1 2025 | |
| $456K | 0.30% | Not reported | Not reported | Q2 2024 | |
| $455K | 0.30% | 0.00% | -11.3% | Q1 2025 | |
| $450K | 0.30% | Not reported | +6.9% | Q3 2024 | |
| $439K | 0.29% | 0.00% | Not reported | Q4 2023 | |
| $429K | 0.28% | 0.00% | -3.8% | Q4 2025 | |
| $423K | 0.28% | 0.00% | +76.8% | Q4 2025 | |
| $416K | 0.27% | 0.00% | +95.2% | Q4 2023 | |
| $415K | 0.27% | Not reported | +7.5% | Q2 2025 | |
| $387K | 0.26% | 0.00% | -91.0% | Q4 2023 | |
| $379K | 0.25% | 0.00% | New | Q1 2026 | |
| $377K | 0.25% | 0.00% | +3.6% | Q1 2024 | |
| $365K | 0.24% | 0.00% | New | Q1 2026 | |
| $351K | 0.23% | 0.00% | -86.5% | Q4 2024 | |
| $348K | 0.23% | 0.00% | Not reported | Q4 2023 | |
| $347K | 0.23% | 0.00% | -77.3% | Q4 2023 | |
| $341K | 0.22% | Not reported | -73.9% | Q4 2023 | |
| $338K | 0.22% | Not reported | Not reported | Q4 2023 | |
| $336K | 0.22% | 0.00% | New | Q1 2026 | |
| $328K | 0.22% | 0.00% | New | Q1 2026 | |
| $312K | 0.21% | Not reported | -19.9% | Q1 2024 | |
| Q4 2025Reported Feb 2, 202667 positions | |||||
| $3.26M | 2.27% | 0.00% | +747.8% | Q4 2023 | |
| $2.4M | 1.67% | Not reported | -2.6% | Q3 2024 | |
| $2.36M | 1.64% | 0.00% | -45.2% | Q4 2023 | |
| $2.27M | 1.58% | Not reported | +248.0% | Q4 2023 | |
| $1.97M | 1.37% | Not reported | +2.3% | Q4 2023 | |
| $1.27M | 0.89% | Not reported | +0.9% | Q4 2023 | |
| $1.05M | 0.73% | 0.00% | Not reported | Q4 2024 | |
| $1.01M | 0.70% | 0.00% | Not reported | Q3 2024 | |
| $978K | 0.68% | Not reported | +46.7% | Q2 2025 | |
| $956K | 0.66% | 0.00% | +1315.7% | Q4 2023 | |
| $933K | 0.65% | 0.00% | +3134.4% | Q4 2023 | |
| $870K | 0.60% | 0.00% | +94.2% | Q4 2023 | |
| $733K | 0.51% | Not reported | +5360.7% | Q4 2023 | |
| $663K | 0.46% | 0.01% | +25.3% | Q2 2024 | |
| $654K | 0.45% | 0.00% | +43.4% | Q2 2025 | |
| $533K | 0.37% | 0.00% | +3492.5% | Q1 2024 | |
| $533K | 0.37% | 0.00% | +787.1% | Q4 2023 | |
| $521K | 0.36% | 0.00% | +439.7% | Q4 2023 | |
| $520K | 0.36% | 0.00% | +473.5% | Q1 2025 | |
| $516K | 0.36% | 0.00% | Not reported | Q1 2025 | |
| $493K | 0.34% | 0.00% | Not reported | Q4 2023 | |
| $472K | 0.33% | 0.00% | -6.0% | Q1 2025 | |
| $465K | 0.32% | 0.00% | -84.9% | Q4 2023 | |
| $448K | 0.31% | 0.00% | New | Q4 2025 | |
| $435K | 0.30% | 0.00% | +236.4% | Q4 2023 | |
| $421K | 0.29% | Not reported | +328.5% | Q4 2023 | |
| $418K | 0.29% | Not reported | +21.7% | Q2 2025 | |
| $398K | 0.28% | Not reported | -11.4% | Q1 2024 | |
| $395K | 0.27% | Not reported | Not reported | Q3 2024 | |
| $384K | 0.27% | 0.00% | +8.8% | Q1 2025 | |
| $381K | 0.26% | 0.00% | Not reported | Q3 2024 | |
| $325K | 0.23% | 0.04% | -57.6% | Q4 2023 | |
| $324K | 0.22% | 0.00% | Not reported | Q1 2024 | |
| $323K | 0.22% | 0.00% | Not reported | Q4 2023 | |
| $299K | 0.21% | 0.00% | +663.9% | Q4 2024 | |
| $264K | 0.18% | 0.00% | Not reported | Q4 2023 | |
| $255K | 0.18% | 0.00% | +2.1% | Q3 2025 | |
| $243K | 0.17% | 0.00% | +16.6% | Q4 2023 | |
| $241K | 0.17% | 0.00% | Not reported | Q4 2023 | |
| $238K | 0.17% | Not reported | Not reported | Q3 2024 | |
| $229K | 0.16% | 0.00% | -68.5% | Q4 2023 | |
| $223K | 0.15% | 0.00% | New | Q4 2025 | |
| $210K | 0.15% | 0.00% | New | Q4 2025 | |
| $209K | 0.15% | 0.00% | -61.7% | Q3 2024 | |
| $204K | 0.14% | 0.00% | +8358.2% | Q1 2025 | |
| $203K | 0.14% | 0.00% | +17.5% | Q4 2023 | |
| DEDUKDuke Energy CORP | $198K | 0.14% | 0.00% | New | Q4 2025 |
| $132K | 0.09% | 0.00% | New | Q4 2025 | |
| $125K | 0.09% | 0.00% | Not reported | Q4 2023 | |
| $114K | 0.08% | 0.00% | New | Q4 2025 | |
| Q3 2025Reported Nov 12, 202546 positions | |||||
| $4.61M | 3.65% | 0.00% | +145.9% | Q4 2023 | |
| $3.26M | 2.58% | 0.00% | +0.2% | Q4 2023 | |
| $2.87M | 2.28% | 0.00% | +29.1% | Q4 2023 | |
| $2.36M | 1.87% | Not reported | -4.0% | Q3 2024 | |
| $2.27M | 1.80% | Not reported | +61.5% | Q4 2023 | |
| $1.88M | 1.49% | Not reported | +2.1% | Q4 2023 | |
| $1.22M | 0.97% | Not reported | -4.4% | Q4 2023 | |
| $1.18M | 0.93% | 0.00% | -0.9% | Q3 2024 | |
| $1.14M | 0.91% | 0.00% | +21.5% | Q4 2023 | |
| $1.02M | 0.81% | 0.00% | +36.6% | Q4 2023 | |
| $930K | 0.74% | 0.00% | +11.9% | Q4 2023 | |
| OBONEZOne Bio, Corp. | $924K | 0.73% | Not reported | +63.3% | Q1 2025 |
| $883K | 0.70% | Not reported | +17.6% | Q4 2023 | |
| $783K | 0.62% | 0.00% | +25.1% | Q4 2023 | |
| $766K | 0.61% | 0.10% | Not reported | Q4 2023 | |
| $718K | 0.57% | 0.00% | Not reported | Q4 2023 | |
| $647K | 0.51% | Not reported | +23.5% | Q2 2025 | |
| $607K | 0.48% | 0.00% | -0.7% | Q4 2023 | |
| $553K | 0.44% | Not reported | Not reported | Q4 2023 | |
| $508K | 0.40% | 0.00% | +19.8% | Q1 2024 | |
| $504K | 0.40% | 0.00% | +23.5% | Q4 2023 | |
| $500K | 0.40% | 0.00% | -27.1% | Q2 2024 | |
| $497K | 0.39% | 0.00% | Not reported | Q4 2023 | |
| $492K | 0.39% | 0.00% | -5.1% | Q4 2023 | |
| $488K | 0.39% | 0.00% | +95.2% | Q1 2025 | |
| $477K | 0.38% | 0.00% | New | Q3 2025 | |
| $465K | 0.37% | Not reported | -4.6% | Q1 2024 | |
| $451K | 0.36% | 0.00% | +20.4% | Q1 2025 | |
| $429K | 0.34% | 0.00% | +31.5% | Q2 2025 | |
| $406K | 0.32% | 0.00% | Not reported | Q4 2024 | |
| $376K | 0.30% | 0.00% | -3.0% | Q1 2025 | |
| $358K | 0.28% | 0.00% | -7.3% | Q1 2024 | |
| $344K | 0.27% | Not reported | +12.3% | Q2 2025 | |
| $339K | 0.27% | Not reported | +5.8% | Q4 2023 | |
| $339K | 0.27% | Not reported | +6.1% | Q2 2024 | |
| $338K | 0.27% | 0.00% | -38.3% | Q4 2023 | |
| $329K | 0.26% | 0.00% | New | Q3 2025 | |
| $324K | 0.26% | Not reported | +10.2% | Q1 2025 | |
| $305K | 0.24% | 0.00% | New | Q3 2025 | |
| $277K | 0.22% | 0.00% | -4.2% | Q4 2024 | |
| $258K | 0.20% | Not reported | -19.7% | Q4 2023 | |
| $249K | 0.20% | Not reported | -13.6% | Q2 2025 | |
| $226K | 0.18% | 0.00% | +5.5% | Q4 2023 | |
| $211K | 0.17% | 0.00% | Not reported | Q1 2025 | |
| $204K | 0.16% | 0.00% | -28.5% | Q4 2023 | |
| $190K | 0.15% | 0.00% | -1.6% | Q4 2023 | |
Premium opens every quarter this fund has filed